
|Videos|September 2, 2015
Pharmacists and Future HRSA Policy Updates
Chris Hatwig, MS, FASHP of Apexus discusses what HRSA policy updates, including 340B "mega guidance," are poised to affect health-system pharmacists.
Advertisement
Chris Hatwig, MS, FASHP of Apexus discusses what HRSA policy updates, including 340B "mega guidance," are poised to affect health-system pharmacists.
This video was shot at ASHP's Summer Meetings and Exposition in Denver in June 2015.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Polycystic Ovary Syndrome Undergoes Name Change: Polyendocrine Metabolic Ovarian Syndrome
2
Amid Mounting Pressure, FDA Commissioner Marty Makary Resigns
3
GLP-1 Receptor Agonists Linked to Improved Survival Outcomes in Breast Cancer
4
From Misdiagnosis to Advocacy: Addressing Bias and Equity in Heart Failure Management
5


































































































































